Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach

Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach

10.3389/fonc.2021.783803

Saved in:

Bibliographic Details
Main Authors:	Tai, Yee Kit, Chan, Karen Ka Wing, Fong, Charlene Hui Hua, Ramanan, Sharanya, Yap, Jasmine Lye Yee, Yin, Jocelyn Naixin, Yip, Yun Sheng, Tan, Wei Ren, Koh, Angele Pei Fern, Tan, Nguan Soon, Chan, Ching Wan, Huang, Ruby Yun Ju, Li, Jing Ze, Frohlich, Juerg, Franco-Obregon, Alfredo
Other Authors:	BIOLOGY
Format:	Article
Language:	English
Published:	FRONTIERS MEDIA SA 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology breast cancer PEMFs EMT patient-derived xenograft chorioallantoic membrane doxorubicin TRPC1 chemotherapy E-CADHERIN CHANNELS SYNERGIZE GROWTH CELLS
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/231277
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Similar Items

Modulated TRPC1 expression predicts sensitivity of breast cancer to doxorubicin and magnetic field therapy: segue towards a precision medicine approach
by: Tai, Yee Kit, et al.
Published: (2022)

GENETIC EPISTASIS BETWEEN TRPC6 MUTATION AND NEPHRIN POLYMORPHISMS IN HEREDITARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS
by: SUN ZIJIN
Published: (2014)

DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER
by: SHAIKH MOHAMMED ISHAQUE
Published: (2012)

Development of stealth liposome coencapsulating doxorubicin and fluoxetine
by: Ong, J.C.-L., et al.
Published: (2014)

Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma
by: Lee, D.H., et al.
Published: (2016)

Ambient and supplemental magnetic fields promote myogenesis via a TRPC1-mitochondrial axis: evidence of a magnetic mitohormetic mechanism
by: Yap, Jasmine Lye Yee, et al.
Published: (2020)

Magnetic fields modulate metabolism and gut microbiome in correlation with Pgc-1α expression: Follow-up to an in vitro magnetic mitohormetic study.
by: Tai, Yee Kit, et al.
Published: (2020)

The Developmental Implications of Muscle-Targeted Magnetic Mitohormesis: A Human Health and Longevity Perspective
by: Franco-Obregón, A, et al.
Published: (2023)

ENHANCEMENT OF SCAFFOLD-MEDIATED MSC CHONDROGENESIS BY PULSED ELECTROMAGNETIC FIELDS
by: CENK CELIK
Published: (2020)

Epithelial-Mesenchymal transition in Breast Cancer Progression
by: KELLY LIM SWEE YING
Published: (2010)

Cell-Derived Vesicles as TRPC1 Channel Delivery Systems for the Recovery of Cellular Respiratory and Proliferative Capacities
by: Kurth, Felix, et al.
Published: (2021)

STEM CELL THERAPY FOR CARTILAGE REGENERATION
by: GOH SHU LIN, DOREEN
Published: (2022)

Brief exposure to directionally-specific pulsed electromagnetic fields stimulates extracellular vesicle release and is antagonized by streptomycin: A potential regenerative medicine and food industry paradigm
by: Wong, Craig Jun Kit, et al.
Published: (2022)

An investigation of the chick chorioallantoic membrane as an alternative model to various biological tissues for permeation studies
by: Tay, S.L.M., et al.
Published: (2014)

Effects of L-carnitine on renal function and oxidative stress in rats with doxorubicin-induced renal injury
by: Dolrudee Boonsanit
Published: (2006)

Liposomal doxorubicin-associated acute hypersensitivity despite appropriate preventive measures
by: Chan, A., et al.
Published: (2014)

Influence of pulsed electromagnetic field with different pulse duty cycles on neurite outgrowth in PC12 rat pheochromocytoma cells
by: Zhang, Y., et al.
Published: (2014)

ESTABLISHING AN EPITHELIAL MESENCHYMAL TRANSITION (EMT) SPECTRUM WITH EMT TRANSCRIPTIONAL DRIVERS
by: TAN MING
Published: (2017)

Liposomal co-encapsulation of quercetin with synergistic chemotherapeutic drugs for breast cancer treatment
by: WONG MAN YI
Published: (2011)

Synergizing transcultural learning of global Englishes: Voices of Chinese exchange students in a Thai university Bangkok (Book Review)
by: Jaewon Jane Ra
Published: (2020)

EPIGENETIC REGULATION OF CELL STATE TRANSITIONS IN TRIPLE NEGATIVE BREAST CANCER
by: TOH LI PING
Published: (2021)

Bergamottin suppresses metastasis of lung cancer cells through abrogation of diverse oncogenic signaling cascades and epithelial-to-mesenchymal transition
by: Ko J.-H., et al.
Published: (2019)

Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients
by: Wong, A.L., et al.
Published: (2014)

Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery
by: Huang, Bu-Wei, et al.
Published: (2018)

Antioxidative and cytoprotective effects of Phyllanthus urinaria L. on doxorubicin-induced cardiotoxicity
by: Linda Chularojmontri
Published: (2007)

Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin
by: Zhou, J., et al.
Published: (2011)

Mollification of doxorubicin (DOX)-mediated cardiotoxicity using conjugated chitosan nanoparticles with supplementation of propionic acid
by: Siva, Durairaj, et al.
Published: (2022)

Pharmacogenetics of Doxorubicin in Asian Breast Cancer Patients
by: SUMAN LAL CHIRAMMAL SUGUNAN
Published: (2011)

STUDY OF ISOPRENYLCYSTEINE CARBOXYLMETHYLTRANSFERASE SUPPRESSION IN CANCER
by: TANG, JINGYI
Published: (2022)

A chemical screen based on an interruption of zebrafish gastrulation identifies the HTR2C inhibitor Pizotifen as a suppressor of EMT-mediated metastasis
by: Nakayama, Joji, et al.
Published: (2022)

EVALUATION OF SOLAMARGINE AS A THERAPEUTIC IN BLADDER CANCER
by: PEE HAI NING
Published: (2016)

Fabrication of double-walled microspheres for the sustained release of doxorubicin
by: Eng, C.T., et al.
Published: (2014)

Lidocaine loaded gelatin/gelatinized tapioca starch films for buccal delivery and the irritancy evaluation using chick chorioallantoic membrane
by: Wannaphatchaiyong, S., et al.
Published: (2021)

The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
by: Loh, C.-Y., et al.
Published: (2022)

Exploiting the TRIP-Br family of cell cycle regulatory proteins as chemotherapeutic drug targets in human cancer
by: Zhi, J.Z., et al.
Published: (2015)

PHARMACODYNAMICS, PHARMACOKINETICS AND PHARMACOGENETICS OF DOXORUBICIN IN SINGAPOREAN BREAST CANCER PATIENTS
by: FAN LU
Published: (2011)

In vitro cytotoxicity of stealth liposomes co-encapsulating doxorubicin and verapamil on doxorubicin-resistant tumor cells
by: Wang, J., et al.
Published: (2012)

Simulation of the delivery of doxorubicin to hepatoma
by: Goh, Y.-M.F., et al.
Published: (2014)

Pharmacokinetics of intravenously administered stealth liposomal doxorubicin modulated with verapamil in rats
by: Wang, J.-C., et al.
Published: (2011)

Synergistic effects of suberoylanilide hydroxamic acid combined with cisplatin causing cell cycle arrest independent apoptosis in platinum-resistant ovarian cancer cells
by: Ong, P.-S., et al.
Published: (2014)